Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Hansa Biopharma AB

Closing information (x1000 DKK)

Closing information 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Turnover 103,259 Less Arrow 24,634 Less Arrow 4,520
Financial expenses 32,502 Less Arrow 886 Less Arrow 190
Earnings before taxes -407,608 More Arrow -398,563 More Arrow -311,949
EBITDA -393,314 Less Arrow -397,725 More Arrow -307,686
Total assets 1,127,581 Less Arrow 736,444 More Arrow 1,063,192
Current assets 1,072,317 Less Arrow 685,206 More Arrow 1,032,724
Current liabilities 176,891 Less Arrow 124,499 Less Arrow 84,643
Equity capital 402,885 More Arrow 550,855 More Arrow 920,613
- share capital 36,776 Less Arrow 33,692 Less Arrow 30,720
Employees (average) 144 Less Arrow 116 Less Arrow 82

Financial ratios

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Solvency 35.7% More Arrow 74.8% More Arrow 86.6%
Turnover per employee 717 Less Arrow 212 Less Arrow 55
Profit as a percentage of turnover -394.7% Less Arrow -1617.9% Less Arrow -6901.5%
Return on assets (ROA) -33.3% Less Arrow -54.0% More Arrow -29.3%
Current ratio 606.2% Less Arrow 550.4% More Arrow 1220.1%
Return on equity (ROE) -101.2% More Arrow -72.4% More Arrow -33.9%
Change turnover 80,620 Less Arrow 20,200 Less Arrow 2,026
Change turnover % 356% More Arrow 456% Less Arrow 81%
Chg. No. of employees 28 More Arrow 34 Less Arrow 19
Chg. No. of employees % 24% More Arrow 41% Less Arrow 30%

Total value of public sale

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.